✦ LIBER ✦

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

✍ Scribed by W. Bensinger; S. Giralt; J. Eary; D. Podoloff; L. Holmberg; R. Alexanian; M. Goodman; A. Serafini; K. Thoelke; J.K. Bryan; R. Champlin

Book ID: 114216233
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 15 KB
Volume: 28
Category: Article
ISSN: 0301-472X
DOI: 10.1016/s0301-472x(00)00264-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Timing of High Dose Melphalan (HDM) and

Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Sobecks; B. Pohlman; S. Andresen; M. Ear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Phase I/II study of tandem high-dose che

Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma

✍ Kazutaka Sunami; Katsuji Shinagawa; Morio Sawamura; Akira Sakai; Yoshio Saburi; 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 277 KB

Health-related quality of life in multip

✍ N. Gulbrandsen; F. Wisløff; L. Brinch; K. Carlson; I. M. Dahl; P. Gimsing; E. Hi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 197 KB

144: Autologous stem cell transplantatio

144: Autologous stem cell transplantation (ASCT) for patients with multiple myeloma (MM): Impact of the degree of plasma cell bone marrow infiltration on mobilization kinetic and transplant outcomes

✍ A. Go; S.A. Gregory; P. Venugopal; J. Shammo; B. McLeod; H.C. Fung 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The feasibility of neoadjuvant high-dose

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study

✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o